Beam Therapeutics

BEAM • NASDAQ • Stock Fundamentals

Beam Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John Evans, with a market cap of $3.0B.

Market Cap$3.0B

Employees436.0

CEOJohn Evans

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Beam Therapeutics

Beam Therapeutics (BEAM) has a market capitalization of $3.0B and trades on NASDAQ.

Beam Therapeutics has approximately 436 employees.